Regulation of complement activation by C-reactive protein

被引:250
作者
Mold, C [1 ]
Gewurz, H
Du Clos, TW
机构
[1] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Dept Med, Albuquerque, NM 87131 USA
[3] Rush Med Coll, Dept Immunol Microbiol, Chicago, IL 60612 USA
[4] Dept Vet Affairs Med Ctr, Albuquerque, NM 87108 USA
来源
IMMUNOPHARMACOLOGY | 1999年 / 42卷 / 1-3期
关键词
complement; inflammation; acute phase reactants; inflammatory mediators;
D O I
10.1016/S0162-3109(99)00007-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C-reactive protein (CRP) is an acute-phase serum protein and a mediator of innate immunity. CRP binds to microbial polysaccharides and to ligands exposed on damaged cells. Binding of CRP to these substrates activates the classical complement pathway leading to their uptake by phagocytic cells. Complement activation by CRP is restricted to C1, C4, C2 and C3 with little consumption of C5-9. Surface bound CRP reduces deposition of and generation of C5b-9 by the alternative pathway and deposition of C3b and lysis by the lectin pathway. These activities of CRP are the result of recruitment of factor H resulting in regulation of C3b on bacteria or erythrocytes. Evidence is presented for direct binding of H to CRP. H binding to CRP or C3b immobilized on microtiter wells was demonstrated by ELISA. Attachment of CRP to a surface was required for H binding. H binding to CRP was not inhibited by EDTA or phosphocholine, which inhibit ligand binding, but was inhibited by a 13 amino acid CRP peptide. The peptide sequence was identical to the region of CRP that showed the best alignment to H binding peptides from Streptococcus pyogenes (M6) and Neisseria gonorrhoeae (Por1A), The results suggest that CRP bound to a surface provides secondary binding sites for H resulting in greater regulation of alternative pathway amplification and C5 convertases. Complement activation by CRP may help limit the inflammatory response by providing opsonization with minimal generation of C5a and C5b-9. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:23 / 30
页数:8
相关论文
共 47 条
[1]  
AGRAWAL A, 1994, J IMMUNOL, V152, P5404
[2]   Transgenic mice expressing rabbit C-Reactive protein exhibit diminished chemotactic factor-induced alveolitis [J].
Ahmed, N ;
Thorley, R ;
Xia, DY ;
Samols, D ;
Webster, RO .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (03) :1141-1147
[3]  
BERMAN S, 1986, J IMMUNOL, V136, P1354
[4]  
Blackmore TK, 1996, J IMMUNOL, V157, P5422
[5]   REGULATION OF THE HUMAN ALTERNATIVE COMPLEMENT PATHWAY - FORMATION OF A TERNARY COMPLEX BETWEEN FACTOR-H, SURFACE-BOUND C3B AND CHEMICAL GROUPS ON NONACTIVATING SURFACES [J].
CARRENO, MP ;
LABARRE, D ;
MAILLET, F ;
JOZEFOWICZ, M ;
KAZATCHKINE, MD .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (11) :2145-2150
[6]   ROLE OF THE YADA-PROTEIN IN PREVENTION OF OPSONIZATION OF YERSINIA-ENTEROCOLITICA BY C3B MOLECULES [J].
CHINA, B ;
SORY, MP ;
NGUYEN, BT ;
DEBRUYERE, M ;
CORNELIS, GR .
INFECTION AND IMMUNITY, 1993, 61 (08) :3129-3136
[7]  
CROWELL RE, 1991, J IMMUNOL, V147, P3445
[8]   The interaction of C-reactive protein and serum amyloid P component with nuclear antigens [J].
DuClos, TW .
MOLECULAR BIOLOGY REPORTS, 1996, 23 (3-4) :253-260
[9]  
DUCLOS TW, 1990, J IMMUNOL, V145, P3869
[10]   DECREASED AUTOANTIBODY LEVELS AND ENHANCED SURVIVAL OF (NZB X NZW) F(1) MICE TREATED WITH C-REACTIVE PROTEIN [J].
DUCLOS, TW ;
ZLOCK, LT ;
HICKS, PS ;
MOLD, C .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 70 (01) :22-27